| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.073 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.084 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.09 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.027 | 0.6 |